Advancing precision oncology with biomarker-driven strategies and digital data solutions

Precision oncology is transforming cancer care by enabling therapies to be matched to the molecular characteristics of individual patients. As biomarker-driven development expands across tumor types, sponsors face increasing challenges in identifying eligible patients, optimizing trial execution and generating the evidence needed to support regulatory, reimbursement and clinical decision-making.

This webinar will explore strategies for advancing precision oncology across the development lifecycle. Topics will include the evolving biomarker landscape and testing approaches, innovative methods for identifying and recruiting biomarker-eligible patients through decentralized and hybrid trial models and the growing role of high-quality clinical data and real-world evidence in accelerating development and demonstrating value.

The discussion will also highlight how AI-enabled data extraction, linked clinical and genomic datasets and modern evidence-generation strategies are helping sponsors gain deeper insights, improve trial efficiency and support broader adoption of precision therapies.

Speakers: